• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

    0.2309 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, May 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 13,216,447
    Open -
    Bid (Size) 0.2132 (2,000)
    Ask (Size) 0.2172 (1,200)
    Prev. Close -
    Today's Range 0.2034 - 0.2309
    52wk Range 0.1626 - 3.870
    Shares Outstanding 75,993,532
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    GOSSAMER BIO DEADLINE MONDAY JUNE 1st: Bragar Eagel & Squire, P.C. Urges Gossamer Bio, Inc. (NASDAQ:GOSS) Investors with Large Losses to Contact the Firm Before Monday June 1st
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Deadline Soon: Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
    From The Law Offices of Frank R. Cruz
    Via Business Wire

    Performance

    YTD
    -92.0%
    -92.0%
    1 Month
    -34.0%
    -34.0%
    3 Month
    -45.7%
    -45.7%
    6 Month
    -93.1%
    -93.1%
    1 Year
    -79.6%
    -79.6%

    More News

    Read More
    News headline image
    GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    GOSSAMER DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GOSS
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Gossamer Bio (GOSS) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Bragar Eagel & Squire, P.C. Urges Gossamer Bio, Inc. (NASDAQ:GOSS) Investors with Large Losses to Contact the Firm Before Monday June 1st
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    DEADLINE APPROACHING: Berger Montague Advises Gossamer Bio, Inc. (NASDAQ: GOSS) Investors to Inquire About a Securities Fraud Class Action by June 1, 2026
    From Berger Montague
    Via GlobeNewswire
    News headline image
    GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS
    From Pomerantz LLP
    Via GlobeNewswire
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    GOSS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026
    From Faruqi & Faruqi, LLP
    Via Business Wire
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill
    News headline image
    GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    Which stocks are gapping on Monday? ↗
    Via Chartmill
    News headline image
    Gossamer Bio Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt with Existing Noteholder Support
    From Gossamer Bio, Inc.
    Via Business Wire
    News headline image
    Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business Update
    From Gossamer Bio, Inc.
    Via Business Wire
    News headline image
    GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Gossamer Bio to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 18, 2026
    From Gossamer Bio, Inc.
    Via Business Wire
    News headline image
    ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GOSS
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Reminds Gossamer Investors that a Class Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (NASDAQ:GOSS) and Encourages Investors with Large Losses to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire

    Frequently Asked Questions

    Is Gossamer Bio, Inc. - Common Stock publicly traded?
    Yes, Gossamer Bio, Inc. - Common Stock is publicly traded.
    What exchange does Gossamer Bio, Inc. - Common Stock trade on?
    Gossamer Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Gossamer Bio, Inc. - Common Stock?
    The ticker symbol for Gossamer Bio, Inc. - Common Stock is GOSS on the Nasdaq Stock Market
    What is the current price of Gossamer Bio, Inc. - Common Stock?
    The current price of Gossamer Bio, Inc. - Common Stock is 0.2309
    When was Gossamer Bio, Inc. - Common Stock last traded?
    The last trade of Gossamer Bio, Inc. - Common Stock was at 05/29/26 04:00 PM ET
    What is the market capitalization of Gossamer Bio, Inc. - Common Stock?
    The market capitalization of Gossamer Bio, Inc. - Common Stock is 17.55M
    How many shares of Gossamer Bio, Inc. - Common Stock are outstanding?
    Gossamer Bio, Inc. - Common Stock has 18M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.